Global Bacillus Calmette Guerin Vaccine Market Research Report 2024

Report ID: 1914203 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Bacillus Calmette Guerin Vaccine Market Overview
    1.1 Product Overview and Scope of Bacillus Calmette Guerin Vaccine
    1.2 Bacillus Calmette Guerin Vaccine Segment by Type
        1.2.1 Global Bacillus Calmette Guerin Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Immune Type
        1.2.3 Therapy Type
    1.3 Bacillus Calmette Guerin Vaccine Segment by Application
        1.3.1 Global Bacillus Calmette Guerin Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Bacillus Calmette Guerin Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Bacillus Calmette Guerin Vaccine Revenue 2017-2028
        1.4.2 Global Bacillus Calmette Guerin Vaccine Sales 2017-2028
        1.4.3 Bacillus Calmette Guerin Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bacillus Calmette Guerin Vaccine Market Competition by Manufacturers
    2.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Bacillus Calmette Guerin Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Bacillus Calmette Guerin Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Bacillus Calmette Guerin Vaccine Market Competitive Situation and Trends
        2.5.1 Bacillus Calmette Guerin Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Bacillus Calmette Guerin Vaccine Players Market Share by Revenue
        2.5.3 Global Bacillus Calmette Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacillus Calmette Guerin Vaccine Retrospective Market Scenario by Region
    3.1 Global Bacillus Calmette Guerin Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Bacillus Calmette Guerin Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
        3.3.1 North America Bacillus Calmette Guerin Vaccine Sales by Country
        3.3.2 North America Bacillus Calmette Guerin Vaccine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
        3.4.1 Europe Bacillus Calmette Guerin Vaccine Sales by Country
        3.4.2 Europe Bacillus Calmette Guerin Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Bacillus Calmette Guerin Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Bacillus Calmette Guerin Vaccine Sales by Region
        3.5.2 Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Bacillus Calmette Guerin Vaccine Sales by Country
        3.6.2 Latin America Bacillus Calmette Guerin Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Bacillus Calmette Guerin Vaccine Sales by Country
        3.7.2 Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Bacillus Calmette Guerin Vaccine Historic Market Analysis by Type
    4.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2022)
5 Global Bacillus Calmette Guerin Vaccine Historic Market Analysis by Application
    5.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Bacillus Calmette Guerin Vaccine Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Sanofi Pasteur
        6.2.1 Sanofi Pasteur Corporation Information
        6.2.2 Sanofi Pasteur Description and Business Overview
        6.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Portfolio
        6.2.5 Sanofi Pasteur Recent Developments/Updates
    6.3 Japan BCG Lab
        6.3.1 Japan BCG Lab Corporation Information
        6.3.2 Japan BCG Lab Description and Business Overview
        6.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Portfolio
        6.3.5 Japan BCG Lab Recent Developments/Updates
    6.4 China National Biotec
        6.4.1 China National Biotec Corporation Information
        6.4.2 China National Biotec Description and Business Overview
        6.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Product Portfolio
        6.4.5 China National Biotec Recent Developments/Updates
    6.5 AJ Vaccines
        6.5.1 AJ Vaccines Corporation Information
        6.5.2 AJ Vaccines Description and Business Overview
        6.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Product Portfolio
        6.5.5 AJ Vaccines Recent Developments/Updates
    6.6 Serum Institute of India
        6.6.1 Serum Institute of India Corporation Information
        6.6.2 Serum Institute of India Description and Business Overview
        6.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Product Portfolio
        6.6.5 Serum Institute of India Recent Developments/Updates
    6.7 Intervax
        6.6.1 Intervax Corporation Information
        6.6.2 Intervax Description and Business Overview
        6.6.3 Intervax Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Intervax Bacillus Calmette Guerin Vaccine Product Portfolio
        6.7.5 Intervax Recent Developments/Updates
    6.8 GSBPL
        6.8.1 GSBPL Corporation Information
        6.8.2 GSBPL Description and Business Overview
        6.8.3 GSBPL Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 GSBPL Bacillus Calmette Guerin Vaccine Product Portfolio
        6.8.5 GSBPL Recent Developments/Updates
    6.9 Statens Serum Institute
        6.9.1 Statens Serum Institute Corporation Information
        6.9.2 Statens Serum Institute Description and Business Overview
        6.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Portfolio
        6.9.5 Statens Serum Institute Recent Developments/Updates
    6.10 Biomed Lublin
        6.10.1 Biomed Lublin Corporation Information
        6.10.2 Biomed Lublin Description and Business Overview
        6.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Product Portfolio
        6.10.5 Biomed Lublin Recent Developments/Updates
    6.11 ANLIS Malbran
        6.11.1 ANLIS Malbran Corporation Information
        6.11.2 ANLIS Malbran Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Portfolio
        6.11.5 ANLIS Malbran Recent Developments/Updates
    6.12 Fundação Ataulpho de Paiva
        6.12.1 Fundação Ataulpho de Paiva Corporation Information
        6.12.2 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product Portfolio
        6.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
    6.13 BB-NCIPD
        6.13.1 BB-NCIPD Corporation Information
        6.13.2 BB-NCIPD Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Product Portfolio
        6.13.5 BB-NCIPD Recent Developments/Updates
    6.14 Taj Pharmaceuticals
        6.14.1 Taj Pharmaceuticals Corporation Information
        6.14.2 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product Portfolio
        6.14.5 Taj Pharmaceuticals Recent Developments/Updates
    6.15 Bio Farma
        6.15.1 Bio Farma Corporation Information
        6.15.2 Bio Farma Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Product Portfolio
        6.15.5 Bio Farma Recent Developments/Updates
    6.16 Microgen
        6.16.1 Microgen Corporation Information
        6.16.2 Microgen Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.16.3 Microgen Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Microgen Bacillus Calmette Guerin Vaccine Product Portfolio
        6.16.5 Microgen Recent Developments/Updates
    6.17 Torlakinstitut
        6.17.1 Torlakinstitut Corporation Information
        6.17.2 Torlakinstitut Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Product Portfolio
        6.17.5 Torlakinstitut Recent Developments/Updates
    6.18 Institut Pasteur de Tunis
        6.18.1 Institut Pasteur de Tunis Corporation Information
        6.18.2 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product Portfolio
        6.18.5 Institut Pasteur de Tunis Recent Developments/Updates
    6.19 IVAC
        6.19.1 IVAC Corporation Information
        6.19.2 IVAC Bacillus Calmette Guerin Vaccine Description and Business Overview
        6.19.3 IVAC Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 IVAC Bacillus Calmette Guerin Vaccine Product Portfolio
        6.19.5 IVAC Recent Developments/Updates
7 Bacillus Calmette Guerin Vaccine Manufacturing Cost Analysis
    7.1 Bacillus Calmette Guerin Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
    7.4 Bacillus Calmette Guerin Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Bacillus Calmette Guerin Vaccine Distributors List
    8.3 Bacillus Calmette Guerin Vaccine Customers
9 Bacillus Calmette Guerin Vaccine Market Dynamics
    9.1 Bacillus Calmette Guerin Vaccine Industry Trends
    9.2 Bacillus Calmette Guerin Vaccine Market Drivers
    9.3 Bacillus Calmette Guerin Vaccine Market Challenges
    9.4 Bacillus Calmette Guerin Vaccine Market Restraints
10 Global Market Forecast
    10.1 Bacillus Calmette Guerin Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Bacillus Calmette Guerin Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Bacillus Calmette Guerin Vaccine by Type (2023-2028)
    10.2 Bacillus Calmette Guerin Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Bacillus Calmette Guerin Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Bacillus Calmette Guerin Vaccine by Application (2023-2028)
    10.3 Bacillus Calmette Guerin Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Bacillus Calmette Guerin Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Bacillus Calmette Guerin Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Bacillus Calmette Guerin Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Bacillus Calmette Guerin Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Bacillus Calmette Guerin Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Bacillus Calmette Guerin Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Bacillus Calmette Guerin Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Bacillus Calmette Guerin Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Bacillus Calmette Guerin Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Bacillus Calmette Guerin Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Bacillus Calmette Guerin Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Bacillus Calmette Guerin Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacillus Calmette Guerin Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
    Table 16. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
    Table 20. North America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Bacillus Calmette Guerin Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Bacillus Calmette Guerin Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Bacillus Calmette Guerin Vaccine Sales (K Units) by Application (2017-2022)
    Table 45. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Bacillus Calmette Guerin Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Bacillus Calmette Guerin Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2022) & (US$/Unit)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Merck Bacillus Calmette Guerin Vaccine Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Sanofi Pasteur Corporation Information
    Table 55. Sanofi Pasteur Description and Business Overview
    Table 56. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product
    Table 58. Sanofi Pasteur Recent Developments/Updates
    Table 59. Japan BCG Lab Corporation Information
    Table 60. Japan BCG Lab Description and Business Overview
    Table 61. Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Japan BCG Lab Bacillus Calmette Guerin Vaccine Product
    Table 63. Japan BCG Lab Recent Developments/Updates
    Table 64. China National Biotec Corporation Information
    Table 65. China National Biotec Description and Business Overview
    Table 66. China National Biotec Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. China National Biotec Bacillus Calmette Guerin Vaccine Product
    Table 68. China National Biotec Recent Developments/Updates
    Table 69. AJ Vaccines Corporation Information
    Table 70. AJ Vaccines Description and Business Overview
    Table 71. AJ Vaccines Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. AJ Vaccines Bacillus Calmette Guerin Vaccine Product
    Table 73. AJ Vaccines Recent Developments/Updates
    Table 74. Serum Institute of India Corporation Information
    Table 75. Serum Institute of India Description and Business Overview
    Table 76. Serum Institute of India Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Serum Institute of India Bacillus Calmette Guerin Vaccine Product
    Table 78. Serum Institute of India Recent Developments/Updates
    Table 79. Intervax Corporation Information
    Table 80. Intervax Description and Business Overview
    Table 81. Intervax Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Intervax Bacillus Calmette Guerin Vaccine Product
    Table 83. Intervax Recent Developments/Updates
    Table 84. GSBPL Corporation Information
    Table 85. GSBPL Description and Business Overview
    Table 86. GSBPL Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. GSBPL Bacillus Calmette Guerin Vaccine Product
    Table 88. GSBPL Recent Developments/Updates
    Table 89. Statens Serum Institute Corporation Information
    Table 90. Statens Serum Institute Description and Business Overview
    Table 91. Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Statens Serum Institute Bacillus Calmette Guerin Vaccine Product
    Table 93. Statens Serum Institute Recent Developments/Updates
    Table 94. Biomed Lublin Corporation Information
    Table 95. Biomed Lublin Description and Business Overview
    Table 96. Biomed Lublin Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Biomed Lublin Bacillus Calmette Guerin Vaccine Product
    Table 98. Biomed Lublin Recent Developments/Updates
    Table 99. ANLIS Malbran Corporation Information
    Table 100. ANLIS Malbran Description and Business Overview
    Table 101. ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. ANLIS Malbran Bacillus Calmette Guerin Vaccine Product
    Table 103. ANLIS Malbran Recent Developments/Updates
    Table 104. Fundação Ataulpho de Paiva Corporation Information
    Table 105. Fundação Ataulpho de Paiva Description and Business Overview
    Table 106. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product
    Table 108. Fundação Ataulpho de Paiva Recent Developments/Updates
    Table 109. BB-NCIPD Corporation Information
    Table 110. BB-NCIPD Description and Business Overview
    Table 111. BB-NCIPD Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. BB-NCIPD Bacillus Calmette Guerin Vaccine Product
    Table 113. BB-NCIPD Recent Developments/Updates
    Table 114. Taj Pharmaceuticals Corporation Information
    Table 115. Taj Pharmaceuticals Description and Business Overview
    Table 116. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product
    Table 118. Taj Pharmaceuticals Recent Developments/Updates
    Table 119. Bio Farma Corporation Information
    Table 120. Bio Farma Description and Business Overview
    Table 121. Bio Farma Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Bio Farma Bacillus Calmette Guerin Vaccine Product
    Table 123. Bio Farma Recent Developments/Updates
    Table 124. Microgen Corporation Information
    Table 125. Microgen Description and Business Overview
    Table 126. Microgen Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Microgen Bacillus Calmette Guerin Vaccine Product
    Table 128. Microgen Recent Developments/Updates
    Table 129. Torlakinstitut Corporation Information
    Table 130. Torlakinstitut Description and Business Overview
    Table 131. Torlakinstitut Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Torlakinstitut Bacillus Calmette Guerin Vaccine Product
    Table 133. Torlakinstitut Recent Developments/Updates
    Table 134. Institut Pasteur de Tunis Corporation Information
    Table 135. Institut Pasteur de Tunis Description and Business Overview
    Table 136. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product
    Table 138. Institut Pasteur de Tunis Recent Developments/Updates
    Table 139. IVAC Corporation Information
    Table 140. IVAC Description and Business Overview
    Table 141. IVAC Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. IVAC Bacillus Calmette Guerin Vaccine Product
    Table 143. IVAC Recent Developments/Updates
    Table 144. Production Base and Market Concentration Rate of Raw Material
    Table 145. Key Suppliers of Raw Materials
    Table 146. Bacillus Calmette Guerin Vaccine Distributors List
    Table 147. Bacillus Calmette Guerin Vaccine Customers List
    Table 148. Bacillus Calmette Guerin Vaccine Market Trends
    Table 149. Bacillus Calmette Guerin Vaccine Market Drivers
    Table 150. Bacillus Calmette Guerin Vaccine Market Challenges
    Table 151. Bacillus Calmette Guerin Vaccine Market Restraints
    Table 152. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 153. Global Bacillus Calmette Guerin Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 154. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 155. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 156. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 157. Global Bacillus Calmette Guerin Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 158. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 159. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 160. Global Bacillus Calmette Guerin Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 161. Global Bacillus Calmette Guerin Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 162. Global Bacillus Calmette Guerin Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 163. Global Bacillus Calmette Guerin Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Bacillus Calmette Guerin Vaccine
    Figure 2. Global Bacillus Calmette Guerin Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Immune Type Product Picture
    Figure 4. Therapy Type Product Picture
    Figure 5. Global Bacillus Calmette Guerin Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Others
    Figure 9. Global Bacillus Calmette Guerin Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Bacillus Calmette Guerin Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Bacillus Calmette Guerin Vaccine Sales (2017-2028) & (K Units)
    Figure 12. Bacillus Calmette Guerin Vaccine Sales Share by Manufacturers in 2021
    Figure 13. Global Bacillus Calmette Guerin Vaccine Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Bacillus Calmette Guerin Vaccine Players: Market Share by Revenue in 2021
    Figure 15. Bacillus Calmette Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region in 2021
    Figure 18. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2022)
    Figure 19. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region in 2021
    Figure 20. United States Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Bacillus Calmette Guerin Vaccine by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Bacillus Calmette Guerin Vaccine
    Figure 44. Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
    Figure 45. Bacillus Calmette Guerin Vaccine Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Frequently Asked Questions
Bacillus Calmette Guerin Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bacillus Calmette Guerin Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bacillus Calmette Guerin Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports